Sleep To Reduce Incident Depression Effectively (STRIDE)

This project will assess the effectiveness of a stepped-care model (i.e. digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) followed by face-to-face CBT-I) in improving severity of insomnia and sleep outcomes in an insomnia cohort. This project will also investigate the effectiveness of this stepped-care model in prevention of major depressive disorder, and will test rumination as a mediator of treatment response.

Study Overview

• Status: Completed
• Conditions: Major Depressive Disorder; Rumination; Insomnia, Primary
• Intervention / Treatment: Behavioral: Sleep Hygiene Education Control; Behavioral: digital Cognitive Behavioral Therapy for Insomnia; Behavioral: face-to-face Cognitive Behavioral Therapy for Insomnia

Detailed Description

This project will assess the acute and long-term effectiveness of dCBT-I on Research Domain Criteria (RDoC) sleep parameters: Insomnia Severity Index (ISI), sleep onset latency, and wake after sleep onset in an insomnia cohort including those at elevated risk for depression (e.g. low SES, minority). This will be tested by administering internet-based dCBT-I to people with insomnia and adding face-to-face CBT-I in non-remitters, as well as comparing the RDoC sleep outcomes to an attention control group post-treatment and at 1- and 2-year follow-ups. This study will also determine the acute and long-term effectiveness of face-to-face CBT-I in non-responders to dCBT-I on RDoC sleep outcomes relative to a comparison group post-treatment and at 1- and 2-year follow-ups.

This study will also determine the effects of dCBT-I and CBT-I using a stepped-care model for prevention of major depressive disorder incidence and relapse across 2 years. Specifically, rate of depression of both dCBT-I and CBT-I will be compared to a control group.

This study will also evaluate changes in rumination as a modifiable behavior (post-treatment) that mediates the effect of insomnia treatment on depression risk.

• Study Type: Interventional
• Enrollment (Actual): 1237
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Michigan
    • Novi, Michigan, United States, 48377
      • Henry Ford Medical Center - Columbus

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Determination of Insomnia (ISI > 14)
• And no clinically significant depressive symptoms (Quick Inventory of Depressive Symptomatology < 11)

Exclusion Criteria:

• Age < 18
• Current use of antidepressants for depression
• Bipolar or Seizure disorders
• Known sleep disorders other than insomnia (e.g. obstructive sleep apnea, narcolepsy, restless leg syndrome).
• Current DSM-5 major depressive disorder at baseline.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Sequential Assignment
• Masking: Single

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Sham Comparator: Attention Control; This group receives sleep hygiene education, which serves as a credible control intervention to digital cognitive behavioral therapy for insomnia (dCBT-I). This intervention mimics the web-based patient contact inherent in dCBT-I but is inert with respect to sleep outcomes.	Behavioral: Sleep Hygiene Education Control; Participants are provided with information about good sleep hygiene through 6 weekly emails. Participants practice good sleep hygiene as part of their sleep routine. In Step 1, sleep hygiene control will be exclusively online. In Step 2, sleep hygiene control includes an in-person, face-to-face component.
Experimental: Stepped Care Model; This group receives digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) through the third party program, "Sleepio." Following initial treatment with dCBT-I, individuals who do not experience remission of their insomnia will begin treatment with face-to-face Cognitive Behavioral Therapy for Insomnia with a trained staff member in behavioral sleep medicine.	Behavioral: digital Cognitive Behavioral Therapy for Insomnia; Cognitive Behavioral Therapy for Insomnia administered online through the "Sleepio" program. Treatment utilizes sleep restriction, stimulus control, and cognitive therapy. Treatment is administered through 6 weekly, hour-long online video sessions with an animated figure called "The Prof," which delivers the treatment.; Other Names: Sleepio; dCBT-I; Behavioral: face-to-face Cognitive Behavioral Therapy for Insomnia; Cognitive Behavioral Therapy for Insomnia administered by experienced staff trained in behavioral sleep medicine. Treatment utilizes sleep restriction, stimulus control, and cognitive therapy. Treatment is administered through 6 weekly, hour-long face-to-face sessions with an experienced staff member trained in behavioral sleep medicine.; Other Names: CBT-I
Sham Comparator: Stepped Care Model Control; This group receives digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) through the third party program, "Sleepio." Following initial treatment with dCBT-I, individuals who do not experience remission of their insomnia will receive sleep hygiene education, serving as a credible control intervention for comparison to the Stepped Care Model.	Behavioral: Sleep Hygiene Education Control; Participants are provided with information about good sleep hygiene through 6 weekly emails. Participants practice good sleep hygiene as part of their sleep routine. In Step 1, sleep hygiene control will be exclusively online. In Step 2, sleep hygiene control includes an in-person, face-to-face component.; Behavioral: digital Cognitive Behavioral Therapy for Insomnia; Cognitive Behavioral Therapy for Insomnia administered online through the "Sleepio" program. Treatment utilizes sleep restriction, stimulus control, and cognitive therapy. Treatment is administered through 6 weekly, hour-long online video sessions with an animated figure called "The Prof," which delivers the treatment.; Other Names: Sleepio; dCBT-I
Experimental: digital CBT-I; This group receives digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) through the third party program, "Sleepio." Treatment includes weekly sessions of CBT-I administered over the internet in hour-long video sessions. Daily sleep diaries are recorded online for individual tailoring of treatment.	Behavioral: digital Cognitive Behavioral Therapy for Insomnia; Cognitive Behavioral Therapy for Insomnia administered online through the "Sleepio" program. Treatment utilizes sleep restriction, stimulus control, and cognitive therapy. Treatment is administered through 6 weekly, hour-long online video sessions with an animated figure called "The Prof," which delivers the treatment.; Other Names: Sleepio; dCBT-I

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Preventing major depressive disorder development with dCBT-I/CBT-I stepped care treatment for insomnia.	Clinical interview by phone administered by trained personnel to determine DSM-5 major depressive disorder incidence and relapse. Major depressive disorder will specifically be determined by the structured clinical interview for DSM-5 (SCID-5) at 1- and 2-year follow-ups. Antidepressant history in the past 1 year is collected via online-administered surveys at 1- and 2-year follow-ups.	1 and 2 years after initial randomization.
Effectiveness of Stepped Care model of dCBT-I/CBT-I for insomnia remission.	Insomnia remission rates based on the Insomnia Severity Index. Total score range 0-28 with higher scores meaning more insomnia. Remission = ISI < 8.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.
Mediation of Depression Prevention by Reducing Rumination (Nocturnal rumination)	Rumination as measured by the Pre-Sleep Arousal Scale, Cognitive factor. Scores range from 8 to 40 with higher scores indicating more rumination. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mediation of Depression Prevention by Reducing Rumination (Depressive rumination)	Rumination as determined by the Rumination Response Scale. Scores range from 22-88 with higher scores indicating higher depressive rumination. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.
Mediation of Depression Prevention by Reducing Rumination (Worry)	Rumination as determined by the Penn State Worry Questionnaire. Scores range from 16-80 with higher scores indicating greater worry. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.
Mediation of Depression Prevention by Reducing Rumination (Transdiagnostic)	Rumination as determined by the Perseverative Thinking Questionnaire. Scores range from 15-75 with higher scores indicating greater perseverative thinking. Treatment-related changes in rumination will be operationalized as changes from pre- to posttreatment.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.
Reducing subclinical depressive symptoms with dCBT-I/CBT-I stepped care treatment for insomnia.	Depressive symptoms as measured by the Quick Inventory of Depressive Sympatomatology, 16 item self report version. Reductions in depressive symptoms will be operationalized as (1) pre to posttreatment changes, (2) pretreatment to 1-year follow-up changes, and (3) pretreatment to 2-year follow-up changes.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.
Socioeconomic status as a moderator of depression prevention after stepped care insomnia treatment.	Low socioeconomic status will be defined as annual household income < $20,000. Stepped care treatment will be less effective for preventing depression for patients in poverty as compared to patients above the the poverty line.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.
Racial minority identification as a moderator of depression prevention after stepped care insomnia treatment.	Race will be self reported by patients. Stepped care treatment will be less effective for preventing depression for patients who self-identify as racial minorities (e.g., non-Hispanic black) relative to non-Hispanic white patients.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.
Stepped care insomnia treatment of dCBT-I and CBT-I will significantly improve sleep parameters.	Sleep parameters as captured by self-reported sleep onset latency, wake after sleep onset, and sleep efficiency.	Baseline, upon treatment completion, and then 1 and 2 years after initial randomization.

Collaborators and Investigators

• Sponsor: Henry Ford Health System
• Collaborators: University of Michigan; Big Health Inc.
• Investigators: Principal Investigator: Christopher L Drake, PhD, Henry Ford Health System

Study record dates

Study Major Dates

• Study Start (Actual): March 9, 2018
• Primary Completion (Actual): April 30, 2023
• Study Completion (Actual): June 27, 2024

Study Registration Dates

• First Submitted: October 16, 2017
• First Submitted That Met QC Criteria: October 23, 2017
• First Posted (Actual): October 26, 2017

Study Record Updates

• Last Update Posted (Actual): October 1, 2024
• Last Update Submitted That Met QC Criteria: September 27, 2024
• Last Verified: September 1, 2024

More Information

Terms related to this study

• Keywords: Stepped Care
• Additional Relevant MeSH Terms: Mental Disorders; Nervous System Diseases; Mood Disorders; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Depressive Disorder; Sleep Initiation and Maintenance Disorders; Depressive Disorder, Major
• Other Study ID Numbers: IRB 11586

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No